# TYSABRI

NDC: 64406-008
Generic name: natalizumab
Labeler / Manufacturer: Biogen Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20041123

FDA application: BLA125104

## Active ingredients

- NATALIZUMAB: 300 mg/15mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64406-008"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64406-008
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5fdde91-1989-4dd2-9129-4f3323ea2962